Aldeyra Therapeutics Inc (ALDX)
3.265
+0.18
(+5.66%)
USD |
NASDAQ |
Mar 28, 16:00
3.265
0.00 (0.00%)
After-Hours: 19:55
Aldeyra Therapeutics Cash from Financing (TTM): -1.270M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -1.270M |
September 30, 2023 | -0.2579M |
June 30, 2023 | 1.255M |
March 31, 2023 | 1.249M |
December 31, 2022 | 1.220M |
September 30, 2022 | 1.220M |
June 30, 2022 | 0.0871M |
March 31, 2022 | 120.46M |
December 31, 2021 | 194.50M |
September 30, 2021 | 194.50M |
June 30, 2021 | 220.66M |
March 31, 2021 | 112.71M |
December 31, 2020 | 41.90M |
September 30, 2020 | 50.24M |
June 30, 2020 | 38.86M |
March 31, 2020 | 26.42M |
December 31, 2019 | 23.58M |
September 30, 2019 | 81.53M |
June 30, 2019 | 67.80M |
March 31, 2019 | 76.84M |
December 31, 2018 | 80.53M |
Date | Value |
---|---|
September 30, 2018 | 14.29M |
June 30, 2018 | 40.00M |
March 31, 2018 | 30.94M |
December 31, 2017 | 37.43M |
September 30, 2017 | 37.42M |
June 30, 2017 | 10.49M |
March 31, 2017 | 23.33M |
December 31, 2016 | 12.74M |
September 30, 2016 | 12.69M |
June 30, 2016 | 12.75M |
March 31, 2016 | 19.42M |
December 31, 2015 | 28.47M |
September 30, 2015 | 28.48M |
June 30, 2015 | 28.34M |
March 31, 2015 | 19.15M |
December 31, 2014 | 10.06M |
September 30, 2014 | 11.15M |
June 30, 2014 | 13.27M |
March 31, 2014 | 2.942M |
December 31, 2013 | 3.745M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-1.270M
Minimum
Dec 2023
220.66M
Maximum
Jun 2021
62.67M
Average
40.38M
Median
Cash from Financing (TTM) Benchmarks
United Therapeutics Corp | -11.90M |
Heron Therapeutics Inc | 54.11M |
Esperion Therapeutics Inc | 50.46M |
NovaBay Pharmaceuticals Inc | 4.971M |
Palatin Technologies Inc | 5.553M |